Newest first. 5.2k questions across 107 tags.
The particulars: Shanghai · Norway. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Details up front: list of related substances · QYB. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: Guangzhou · Germany. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: a 30G needle · tirzepatide · 10 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
Conditions: PeptideMeter · 98.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
The case in front of me: 6.67 mg/mL · tirzepatide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
The case in front of me: a 25G drawing needle · tirzepatide · 1 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I…
Setup, so nobody has to ask: Wuxi · New Zealand. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: minus 80 °C · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
The particulars: triglycerides · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
What I have: Janoshik · mazdutide. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am comfortable with the…
What I am working with: QSC · peptide mapping. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude…
The lot number on the vial matches the certificate, which at least rules out the easy problem. Everything I have found on this is either a forum aside or a product…
Setup, so nobody has to ask: a residual-solvent screen · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I…
The specifics, since they change the answer: Nantong · Canada. I have read the primary source rather than the summary, which has left me with more questions. I…
Setup, so nobody has to ask: 30 °C · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
Setup, so nobody has to ask: 98.2% · mazdutide · TFC. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
Setup, so nobody has to ask: early satiety · a GLP-1 receptor agonist. The empirical answer seems settled. The explanation does not. If the honest answer is that…
I am reading the trial table rather than the press release, which is why the numbers differ. I can predict the outcome but I cannot explain it, which means I will get…
I have three data points across nine months, which I hope is enough to see a trend. I can parse the result. I am less sure what it licenses me to conclude. I have…
Setup, so nobody has to ask: SGN · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
Numbers first: 2 mg · 0.5 mL · sterile water for injection · semaglutide. This is a planning question. I know what my options are; I do not know how to weigh them.…
What I have: eGFR · HbA1c · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
I am asking mechanistically rather than practically — I want the model, not the protocol. This should be a straightforward calculation and I keep getting two…